Lobectomy vs. sublobectomy for stage I non-small-cell lung cancer: a meta-analysis.

ABSTRACT:

Background

Although lobectomy is widely regarded as the treatment of choice for early-stage non-small-cell lung cancer (NSCLC), sublobectomy (segmentectomy and wedge resection) has emerged as an alternative modality over the years. Only a handful of studies has compared the treatment effects of these two surgical interventions. This study aimed to analyze the treatment effects between lobectomy and sublobectomy on the survival outcomes of patients with stage I NSCLC systematically.

Methods

PubMed, Embase, and the Cochrane Library were systematically searched from their inception up to February 2019 for studies that compared the survival outcomes of lobectomy and sublobectomy. Studies that reported the diagnosis of stage I NSCLC by imaging or pathophysiology, lobectomy as int

SUBMITTER: Lv F 

PROVIDER: S-EPMC8246236 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature